AAFP Feline Retrovirus Management Guidelines (2020) — FeLV and FIV testing, management, and prevention

The 2020 AAFP Feline Retrovirus Management Guidelines (published in the Journal of Feline Medicine and Surgery) update the heavily referenced 2008 version and aim to give practitioners current information on feline retrovirus infections to optimize patient care. These Guidelines focus on feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections, which occur in cats worldwide.

Prevention emphasizes that The spread of these viruses can be minimized through education, testing, and vaccinations. The guidelines also note an emerging trend: screening for FeLV and FIV is increasingly shifting from animal shelters (where cats are adopted) to veterinary practices, where animals receive comprehensive care, and that quantitative testing can better inform clinical decision-making as a cat's immune response and virus levels change over time.

Pet-food relevance: retrovirus testing/management is part of the feline preventive-care picture alongside vaccination (covered by the vaccination topic) and the infectious-disease fact sheets. Written in paraphrase mode (AAFP/SAGE copyrighted); exact guideline title, the FeLV/FIV focus, and the prevention wording are anchored verbatim.

Claims (verified C1 substrings of source_file — paraphrase mode)

• 2020 AAFP Feline Retrovirus Management Guidelines
• These Guidelines focus on feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections, which are found in cats worldwide
• The spread of these viruses can be minimized through education, testing, and vaccinations
• 2008 Retrovirus Testing and Management Guidelines
• screening for FeLV and FIV is increasingly shifting from animal shelters, where cats are adopted, to veterinary practices